We are Cordis
コーディスは血管内治療に関するテクノロジーを提供する、独立した顧客志向の企業です。
コーディスは60年にわたる歴史において、世界初のガイディングカテーテルや冠動脈薬剤溶出ステントなど画期的な技術のパイオニアとして医療に貢献し、また世界70カ国にてビジネスを展開しています。
私たちは、イノベーション、臨床における見地、トレーニング、そしてその他のサービスを通じ、何百万人もの命を救うために努力を続けています。私たちの使命は、患者様の生命力向上に貢献し、医療費の削減を支援するための、差別化されたソリューションを開発することで、お客様に喜んでいただくことです。
私たちは決してイノベーションを止めません。私たちはこれからも、バスキュラークロージャ―、ラディアル、ペダルアクセス、インターベンションに注力し、将来を見据えて、血管内治療分野の困難な課題に対処していきます。
研究開発、企業文化、臨床成果、業務における規律など、私たちが前進すれば、お客様、患者様、社員、そして株主も同じく前進する事になります。私たちは、私たちの可能性を解き放ちます。そうすることで、お客様の可能性をも広げることが出来ると信じているからです。
A dynamic new business model
新たな投資パートナーと経験豊富な経営陣のもと、私たちは自らを改革し、顧客を中心とするコーディス・ブランドを再生していきます。
私たちは、スピードや機敏性、価値を最大化するために構築された市場投入モデルを持つ独立したイノベーションアクセラレータであるCordis Xと協力し、限界に挑み、そして挑戦し続けます。
Our Leadership Team
Scott Drake
Chief Executive Officer
CEO Scott Drake has a long history of developing commercial excellence and building world-class medical device organizations – along with the reputation of attracting, retaining, and developing world-class talent. He has over 30 years of medical device experience including as the President and CEO of the Spectranetics Corporation, where he increased shareholder value from approximately $170 million to $2.2 billion during his six-year tenure. Mr. Drake has served on numerous boards of directors, including Cordis, Zayo Group Holdings, which Digital Colony and EQT acquired for $14.3 billion, Paragon 28, Inc., ViewRay, Bolder Surgical, the Medical Device Manufacturers Association (MDMA), and he has served as the Executive Chairman of Cordis and the Chairman of Atricure, Inc.
Mr. Drake is driven by his passion for patient care and developing new approaches to improving patients’ quality of life. Mr. Drake is an Ernst & Young 2014 Entrepreneur of The Year™ and holds a B.S. in Business Administration from Miami University of Ohio.
Duke Rohlen
Executive Chairman (Cordis-X)
Duke Rohlen serves as a member on the Cordis Board of Directors and CEO of Cordis-X – an independent innovation hub designed to provide a pipeline of new products for Cordis. Mr. Rohlen also serves as CEO and Managing Director of Ajax Health, a team of entrepreneurs, business strategists, and investors that identify, invest in, and scale disruptive healthcare technologies. To date, Ajax-developed technologies have generated over $750 million in annual revenue for their acquirers and have been used to treat over one million patients. Over the past 15 years, Mr. Rohlen has built and sold four medical device companies with a combined enterprise value of over $1.7 billion. In addition to his roles at Cordis and Ajax, Mr. Rohlen currently serves on the boards of directors of Ablacon (Executive Chairman), Serpex Medical (Executive Chairman), XII Medical (Executive Chairman), Foresight Mental Health (Director), and the United States Ski and Snowboard Association (Trustee). Prior to Ajax, Mr. Rohlen co-founded and served as Chairman and CEO of EPIX Therapeutics (acquired by Medtronic), co-founder and CEO of Spirox (acquired by Entellus), and co-founder and CEO of CV Ingenuity (acquired by Covidien). Prior to CV Ingenuity, he also served in a variety of roles at FoxHollow Technologies before being named President. In that role, he led the sale of the company to ev3 (now Medtronic). Mr. Rohlen received an M.B.A. from Harvard Business School and a B.A. from Stanford University
Champ Davis
Chief Operating Officer
Champ Davis, Chief Operating Officer, has extensive experience guiding companies through transformative operational changes. He is passionate about innovation and building high-performing teams and businesses. As COO, Mr. Davis turns strategic plans into reality enabling companies to achieve their goals. Prior to this role, he was the SVP of Global Transformation at Cordis. Previously, he worked at Royal Philips (formerly Spectranetics) for nine years as Global VP of Order-to-Fulfillment, Transformation, Integration, and Field Service as well as in a variety of roles across R&D, M&A / Integration, and Operations. Mr. Davis spent his earlier career at Biomet, Johnson & Johnson, InnerPulse, and Becton Dickinson.
Mr. Davis has an MBA from Duke University, a BS in Mechanical Engineering from Clemson, and an MS in Biomedical Engineering from the University of Tennessee. He is a licensed Professional Engineer in the state of Florida, and the holder of 9 US Patents.
Christopher Scully
Chief Financial Officer
CFO Christopher Scully plays an instrumental role in helping accelerate Cordis’ growth as it establishes itself as a technological leader. Most recently, Scully was Executive Vice President and Chief Financial Officer for PPD, where he worked with leaders across the enterprise to meet or exceed the company’s financial targets for four consecutive years and deliver double-digit growth. He played an instrumental role in the company’s IPO and, ultimately, its sale to Thermo Fisher Scientific for an enterprise value greater than $20 Billion. Prior to his tenure with PPD, he served more than 20 years with Pfizer. He earned his MBA at NYT Stern School of Business and attended the Harvard Business School Pfizer Leadership Development Program. He received a B.E. from Manhattan College.
Nancy Pounder
Chief Human Resources Officer
Chief of Human Resources Nancy Pounder is a dynamic and versatile HR professional with 25 years of global experience including business partnering, organizational planning, talent management, executive development and coaching, and mergers & acquisitions. At Cordis, she is focused on attracting, retaining, and developing top-tier talent to transform Cordis into a pioneering cardiovascular leader. As former Global Vice President, Human Resources at Zimmer Biomet, her scope of responsibilities included programs covering more than 10,000 employees. She previously served as Global VP, Human Resources at Spine, Dental, CMF & Thoracic, and Robotics where her strategic mindset, executional expertise, and balanced leadership style were hallmarks of her tenure with the organization. In addition, Pounder spent more than 15 years at General Electric in global HR leadership positions across several business sectors. She earned a Master of Industrial Relations and Human Resources at the University of Toronto and received her B.A. from the University of Victoria.
George Adams, MD, MHS, MBA, FACC, FSCAI
Chief Medical Officer
CMO Dr. George Adams comes to Cordis with a distinguished combination of clinical practice, medical research, and product development experience. He is globally recognized for his expertise in the treatment of peripheral vascular disease in patients with critical limb ischemia (CLI) and treatment of coronary artery disease in patients with acute coronary syndromes. He is involved in the development of regional and national systems of care for the treatment of CLI, ST-Elevation Myocardial Infarction (STEMI), and management of complex coronary and peripheral vascular disease. Dr. Adams plays an integral role in global peer education and is a sought-after speaker and well-published researcher, serving as primary investigator for multiple clinical trials. He earned his Doctor of Medicine at East Carolina University, a Master of Health Science degree from Duke University and his B.S. degree at North Carolina State University.
Dodd Gray
Chief Legal Officer
Chief Legal Officer Dodd Gray is a highly experienced attorney grounded in both U.S. and international general corporate practice and the management of complex compliance and legal affairs for multi-national companies in the medical technology field. He comes to Cordis with a proven record acquired over 25 years of providing timely, strategically sound counsel for the pragmatic management of issues confronting highly regulated businesses. Prior to two years of private consultancy, Gray served over eight years first as Vice President Legal, Compliance, and Business Development EMEAC and then as Associate General Counsel – International for St. Jude Medical, which was acquired by Abbott Laboratories in 2017. He previously served as Vice President and Senior Legal Counsel at Hill-Rom and in a series of roles of increasing responsibility in the U.S. and Europe for Guidant Corporation, culminating in the position of Vice President and General Counsel – International Operations before transitioning to Boston Scientific upon completion of the $27B merger agreement. Gray earned his Juris Doctor, Law at The Ohio State University and a B.S. degree at Purdue University.
Matthew Muscari
President, Americas
Matt Muscari, President of the Americas, heads a leadership team responsible for commercial operations, including global and regional marketing, sales, and sales operations for the Americas. After proudly serving in the United States Marine Corps, he spent the last 20 years in medical device commercial leadership with experience at US Surgical, Intuitive Surgical and, most recently, Cardiovascular Systems, Inc. (CSI) where he led the Peripheral Vascular Commercial organization. Muscari directed CSI’s growth of the U.S. Office Based Lab (OBL) channel to constitute 50% of the business. With a passion for market disruption, breakthrough therapies and building a team culture that is motivated to win, Muscari shares Cordis’ bold vision to delight our physician customers by developing differentiated solutions that improve patient vitality and lower the cost of care. Matt earned his Bachelor’s degree at Hawaii Pacific University.
Dominique Boulet
President, International
Dominique Boulet brings more than 25 years of experience in the medical devices and diagnostics industry to his role as leader of the EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific) regions of Cordis. During his 20-year tenure with Johnson and Johnson, he served in roles including sales and marketing, business development, strategy and general management roles. He was most recently President and Chairman of J&J’s medical business in Germany and Senior Vice President for the DACH region (Austria, Switzerland and Germany). He was instrumental in the integration of Ethicon into J&J’s surgical care group. Dominique transformed the overall business in the region to a solution provider, making it the fastest-growing EMEA market in 2014. His depth of expertise in P&L management, mergers and acquisitions, and developing mature and emerging markets positions him to play a pivotal role as Cordis continues its path of worldwide growth. Dominique earned his MBA at Universita Bocconi in Italy and a degree in international management and business at the ISCID Business School in France.
Chris Bingham
Vice President, Global Marketing & Strategy
Chris Bingham, Vice President of Global Marketing & Strategy, leads the team responsible for global portfolio management, branding, and upstream marketing. Mr. Bingham brings more than 20 years of experience in marketing, strategy and business development roles spanning start-ups to Fortune 100 companies. Most recently, Mr. Bingham led the Global Marketing & Training team for Sonova’s cochlear implant business, driving transformational growth by leading the largest product launch in the business’s history. Mr. Bingham was in instrumental in driving growth at Medtronic across the coronary and peripheral vascular businesses, leading the acquisition of Invatec and the global commercialization of the In.Pact Admiral drug-coated balloon. Chris is excited to be part of leading transformation and growth at Cordis. Chris earned a bachelor’s degree in biology from Utah State University and an MBA from the Huntsman School of Business.
採用情報
全世界で3,500人以上の従業員を擁する当社の一員になりませんか？
会社概要
社名： コーディスジャパン合同会社
職務執⾏者社⻑： ギャレス・リー
所在地： 〒163-1306 東京都新宿区西新宿6-5-1 新宿アイランドタワー6階
TEL： 0120-888-478
Global Headquarters
14201 Northwest 60th Avenue
Miami Lakes, FL 33014
PHONE: 786.313.2000
医療機関等との関係の透明性に関する指針
コーディスジャパン合同会社は、「医療機関等との関係の透明性に関する指針」（以下「本指針」）を当社の指針として定め、当社の事業活動に伴う医療機関・医療関係者等への資金提供実績の情報を公開します。